Leo Pharma Archives

Home Leo Pharma

Latest Posts

News and Trends 5 Oct 2016

New Psoriasis Antibody Therapy puts pressure on Best-Seller drug Humira

New results from a Phase III trial show that guselkumab, an antibody therapy for the autoimmune disease plaque psoriasis, is performing better than the number one best-seller drug Humira (adalimumab) from AbbVie.…

October 5, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 21 Nov 2018

Leo Pharma Enters Partnership to Develop Topical Treatment for Rare Skin Cancer

The Danish company Leo Pharma and the US biotech PellePharm have joined forces to develop a topical treatment for rare forms of skin cancer. In the partnership, dermatology specialist Leo Pharma is…

November 21, 2018 - 2 minutesmins - By Jonathan Smith

In Depth 17 Oct 2017

Blockbuster Potential: How Biotech is Paving the Way to Clear Skin from Psoriasis

Though the psoriasis market is teeming with effective products, companies have developed ways to devise new, more effective modes of treatment. Psoriasis is a common autoimmune disorder that affects the…

October 17, 2017 - 7 minutesmins - By Diana Kwon

More News! 20 Jun 2017

Belgian Llama Antibody Developer gets Second Preclinical Milestone from Danish Pharma

argenx's 2015 deal with Leo Pharma for anti-inflammatory antibodies continues to pay off, though it hasn't been disclosed by how much exactly. Two years ago, Ghent-based argenx and Danish Leo Pharma…

June 20, 2017 - 1 minutemin - By Evelyn Warner

News and Trends 20 Jul 2017

Update: Danish Psoriasis Drug Gets EU Approval Despite Suicide Links

Update (20/07/2017): The European Commision has granted LEO Pharma marketing authorization for Kyntheum (brodalumab), making it the first biologic drug that targets IL-17a. Published 22/05/2017 The EMA has taken up a…

July 20, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 2 Nov 2016

Antibody Therapies are here to Revolutionize Dermatology

Leo Pharma is offering MorphoSys no less than €111.5M per antibody treatment with applications in dermatology, a very profitable field with big unmet needs. New cancer therapies might also arise…

November 2, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

leo pharma astrazeneca dermatology biologics

News and Trends 4 Jul 2016

Danish Pharma enters in the Biologics arena with Antibody Buy-out

Leo Pharma is acquiring rights to two of AstraZeneca's candidates. The targeted indications are atopic dermatitis and psoriasis - autoimmune conditions getting more and more attention. Based near Copenhagen (Denmark),…

July 4, 2016 - 3 minutesmins - By Denise Neves Gameiro

llama leo pharma argen x skin milestone inflammatory

News and Trends 3 Feb 2016

When the Llama met the Lion: Antibodies Unlock Milestone Payment for Skin Disease

ArGEN-X in Ghent (Belgium) combines the diversity of the llama immune system with a clinical antibody pipeline which Leo Pharma (Denmark), is developing to treat inflammatory skin conditions. These llama mAb platforms allow arGEN-X to…

February 3, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 10 Dec 2015

Infographic: The Anatomy of European Biotech

Which part of our body do European biotechs prefer to target? And how diversified are the biotech companies in Europe nowadays? Let’s take the human body to know who works…

December 10, 2015 - 1 minutemin - By Nicolas Sainte-Foie

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

Download Inpart’s latest report

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inpart, the leading platform for biopharma partnering